Vol I - Nº 2 - Abril de 2011 - Publicação Quadrimestral (ISSN 1853-4244)
ARTÍCULOS ORIGINAIS
- Are we ready to replace anti TNF with anti IL12-23 in Psoriasis and Psoriatic Arthritis.
Luciana Pereira Almeida De Piano,Ricardo Prado Golmia, Morton A. Scheinberg.
- Cardio-metabolic comorbidities in patients with psoriasis
Alessandra Cozzi, Paolo Gisondi and Giampiero Girolomoni.
- Rasch analysis confirms the validity of using the Health Assessment Questionnaire Disability Index in different disease subgroups in psoriatic arthritis
William J. Taylor, Philip S. Helliwell.
- HLA-C, -DR, -DQ and POU5F1/ OTF3 on Risk for Psoriasis in the Venezuelan population
Z. Layrisse, M. Fernández-Mestre, V. Ogando, O. Balbas, M.T. Merida.
- Severidad, calidad de vida y evolución de la psoriasis. Su relación en nuestra población.
María Marcela Lustia, Paula Carolina Luna, Mabel Jimena Nocito, María Laura Castellanos Posse, Carolina Marchesi, Nadia Guadalupe Cañadas y Miguel Angel Mazzini.
- PSORIASIS Y ARTRITIS PSORIÁSICA: TERAPIA CON ANTAGONISTAS DEL FACTOR DE NECROSIS TUMORAL ALFA Y TUBERCULOSIS
Villani Bonecco Ianina Daniela, Stecher Daniel, Saposnik Miriam, Ubogui Javier.
- Post Marketing Safety Registries in Dermatology: how do we identify important safety issues as quickly as possible?
Xinaida Taligare Lima, Alexandra Boer Kimball.
CASO CLINICO